| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5599629 | Atherosclerosis | 2017 | 8 Pages |
Abstract
Lower sTWEAK concentrations are associated with atherosclerotic burden and atheromatosis progression in CKD patients free of clinical CVD. These data suggest that sTWEAK could serve as a biomarker to predict CV risk before clinical manifestations.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Valvanera Fernández-Laso, Nerea Méndez-Barbero, Jose M. Valdivielso, Angels Betriu, Elvira Fernández, Jesús Egido, Jose L. MartÃn-Ventura, Luis M. Blanco-Colio,